CORC  > 复旦大学上海医学院
Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study
Xu, Rui-Hua; Li, Jin; Bai, Yuxian; Xu, Jianming; Liu, Tianshu; Shen, Lin; Wang, Liwei; Pan, Hongming; Cao, Junning; Zhang, Dongsheng
刊名JOURNAL OF HEMATOLOGY & ONCOLOGY
2017
卷号10
关键词Fruquintinib Metastatic colorectal cancer Progression-free survival VEGFR
ISSN号1756-8722
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3614741
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Xu, Rui-Hua,Li, Jin,Bai, Yuxian,et al. Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY,2017,10.
APA Xu, Rui-Hua.,Li, Jin.,Bai, Yuxian.,Xu, Jianming.,Liu, Tianshu.,...&Su, Weiguo.(2017).Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study.JOURNAL OF HEMATOLOGY & ONCOLOGY,10.
MLA Xu, Rui-Hua,et al."Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study".JOURNAL OF HEMATOLOGY & ONCOLOGY 10(2017).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace